Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marina Naldi

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
Frontiers in Chemistry|April 9, 2024
HSA-nanobinders crafted from bioresponsive prodrugs for combined cancer chemoimmunotherapy-an <i>in vitro</i> explorationMatilde Tubertini, Luca Menilli, Celeste Milani, et al.
International Journal of Molecular Sciences|March 28, 2024
Association between Albumin Alterations and Renal Function in Patients with Type 2 Diabetes MellitusMarta Nugnes, Maurizio Baldassarre, Danilo Ribichini, et al.
Thrombosis Research|November 23, 2019
In vitro thrombogenicity of drug-eluting and bare metal stentsTullio Palmerini, Chiara Barozzi, Luciana Tomasi, et al.
Analytical and Bioanalytical Chemistry|July 21, 2012
Fluorescence biosensing micropatterned surfaces based on immobilized human acetylcholinesteraseManuela Bartolini, Marina Naldi, Dan V Nicolau, et al.
Journal of Medicinal Chemistry|October 15, 2019
Dual-Acting Cholinesterase-Human Cannabinoid Receptor 2 Ligands Show Pronounced Neuroprotection in Vitro and Overadditive and Disease-Modifying Neuroprotective Effects in VivoMatthias Scheiner, Dominik Dolles, Sandra Gunesch, et al.
Hepatology (Baltimore, Md.)|March 12, 2021
Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic ImplicationsMaurizio Baldassarre, Marina Naldi, Giacomo Zaccherini, et al.
European Journal of Medicinal Chemistry|June 12, 2019
Discovery of novel benzofuran-based compounds with neuroprotective and immunomodulatory properties for Alzheimer's disease treatmentSerena Montanari, Ali Mokhtar Mahmoud, Letizia Pruccoli, et al.
European Journal of Medicinal Chemistry|August 4, 2019
Tacrine-O-protected phenolics heterodimers as multitarget-directed ligands against Alzheimer's disease: Selective subnanomolar BuChE inhibitorsJesús M Roldán-Peña, Valle Romero-Real, Javier Hicke, et al.
Chemico-Biological Interactions|August 4, 2025
Isofagomine-coumarin hybrids: bridging cancer and Alzheimer's diseaseTeresa C Santos Evangelista, Aday González-Bakker, Adrián Puerta, et al.
European Journal of Medicinal Chemistry|February 25, 2019
Design, biological evaluation and X-ray crystallography of nanomolar multifunctional ligands targeting simultaneously acetylcholinesterase and glycogen synthase kinase-3Killian Oukoloff, Nicolas Coquelle, Manuela Bartolini, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Frontiers in Chemistry|April 9, 2024
HSA-nanobinders crafted from bioresponsive prodrugs for combined cancer chemoimmunotherapy-an <i>in vitro</i> explorationMatilde Tubertini, Luca Menilli, Celeste Milani, et al.
International Journal of Molecular Sciences|March 28, 2024
Association between Albumin Alterations and Renal Function in Patients with Type 2 Diabetes MellitusMarta Nugnes, Maurizio Baldassarre, Danilo Ribichini, et al.
Thrombosis Research|November 23, 2019
In vitro thrombogenicity of drug-eluting and bare metal stentsTullio Palmerini, Chiara Barozzi, Luciana Tomasi, et al.
Analytical and Bioanalytical Chemistry|July 21, 2012
Fluorescence biosensing micropatterned surfaces based on immobilized human acetylcholinesteraseManuela Bartolini, Marina Naldi, Dan V Nicolau, et al.
Journal of Medicinal Chemistry|October 15, 2019
Dual-Acting Cholinesterase-Human Cannabinoid Receptor 2 Ligands Show Pronounced Neuroprotection in Vitro and Overadditive and Disease-Modifying Neuroprotective Effects in VivoMatthias Scheiner, Dominik Dolles, Sandra Gunesch, et al.
Hepatology (Baltimore, Md.)|March 12, 2021
Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic ImplicationsMaurizio Baldassarre, Marina Naldi, Giacomo Zaccherini, et al.
European Journal of Medicinal Chemistry|June 12, 2019
Discovery of novel benzofuran-based compounds with neuroprotective and immunomodulatory properties for Alzheimer's disease treatmentSerena Montanari, Ali Mokhtar Mahmoud, Letizia Pruccoli, et al.
European Journal of Medicinal Chemistry|August 4, 2019
Tacrine-O-protected phenolics heterodimers as multitarget-directed ligands against Alzheimer's disease: Selective subnanomolar BuChE inhibitorsJesús M Roldán-Peña, Valle Romero-Real, Javier Hicke, et al.
Chemico-Biological Interactions|August 4, 2025
Isofagomine-coumarin hybrids: bridging cancer and Alzheimer's diseaseTeresa C Santos Evangelista, Aday González-Bakker, Adrián Puerta, et al.
European Journal of Medicinal Chemistry|February 25, 2019
Design, biological evaluation and X-ray crystallography of nanomolar multifunctional ligands targeting simultaneously acetylcholinesterase and glycogen synthase kinase-3Killian Oukoloff, Nicolas Coquelle, Manuela Bartolini, et al.
Pageof 7